Christine Bellon - Jan 31, 2025 Form 4 Insider Report for Beam Therapeutics Inc. (BEAM)

Role
Chief Legal Officer
Signature
By: /s/ Christine Bellon
Stock symbol
BEAM
Transactions as of
Jan 31, 2025
Transactions value $
$0
Form type
4
Date filed
2/3/2025, 04:05 PM
Previous filing
Jan 6, 2025
Next filing
Feb 19, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BEAM Stock Option (Right to Buy) Award $0 +40K $0.00 40K Jan 31, 2025 Common Stock 40K $25.92 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option vests in equal monthly installments each month following the date of grant for the subsequent 48 months, subject to the Reporting Person's continued service with BEAM through each vesting date.